Skip to main content
. 2014 May 8;15(5):8037–8048. doi: 10.3390/ijms15058037

Figure 1.

Figure 1.

Phoshphorylated GATA binding protein 4 (p-GATA4) and brain natriuretic peptide (BNP) expressions in cirrhotic cardiomyopathy (CCM) hearts. (A) The p-GATA4 and BNP expressions (n = 6 in each group) were increased in CCM and reduced by silymarin, baicalein, SHSST (San Huang Shel Shin Tang), and SHSSTc low dose and high dose treatments; (B) The normalized protein expression folds of p-GATA4 with GATA4; (C) The normalized protein expression folds of BNP with α-tubulin (the scale bars is also presented as the normalized folds with α-tubulin); (D) Echocardiography analysis images (n = 6 in each group) of the heart function is compared by the left ventricular systolic and diastolic distance (cm). ** p < 0.01, *** p < 0.001 compared with control group; # p < 0.05, ## p < 0.01, ### p < 0.001 compared with CCM group.